Clinical Trials Directory

Trials / Completed

CompletedNCT05099263

The Vivaer Procedure for Treatment of the Septal Swell Bodies (SWELL)

The Vivaer Procedure for Treatment of the Septal Swell Bodies for Airway Obstruction - A Prospective Open-Label Multicenter Study (SWELL)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Aerin Medical · Industry
Sex
All
Age
22 Years – 85 Years
Healthy volunteers
Accepted

Summary

Post-market study to access the clinical use of the Vivaer Arc Stylus to treat Septal Swell Bodies (SSB).

Detailed description

Prospective, Open-Label, Multicenter, Single Arm Study of the Aerin Medical Vivaer ARC Stylus to treat Septal Swell Bodies (SSB) to improve symptoms in adults diagnosed with nasal obstruction attributed to SSB.

Conditions

Interventions

TypeNameDescription
DEVICEVivaer Arc StylusThe Vivaer procedure will be performed in the study clinic using the Vivaer ARC Stylus and Aerin Console. The Vivaer ARC Stylus is a disposable handheld device capable of delivering bipolar radiofrequency energy to tissue when connected to the Aerin Console radiofrequency generating device. Participants in this study will undergo bilateral treatment of the nasal airway in a single study session.

Timeline

Start date
2021-09-14
Primary completion
2022-04-27
Completion
2024-10-16
First posted
2021-10-29
Last updated
2025-08-28
Results posted
2024-08-21

Locations

9 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05099263. Inclusion in this directory is not an endorsement.